HNSCC tissues; adjacent non-tumor tissues; xenograft tumors
SCC-9; SCC-15; SCC-25; CAL-27; HOK
cell line-derived xenograft
PI3K/AKT/mTOR (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); apoptosis (promotes); EMT (inhibits); metastasis (inhibits)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); TUNEL; Cohort Study; Survival Analysis
Low circSHPRH expression was associated with shorter overall survival and histological grade; circSHPRH may serve as a potential biomarker for HNSCC diagnosis, prognosis, and therapeutic response prediction.
CircSHPRH is a human circRNA derived from SHPRH and is significantly downregulated in HNSCC tissues and cell lines. In this study, circSHPRH overexpression suppressed proliferation, migration, invasion, EMT-related marker changes, and xenograft tumor growth while promoting apoptosis. Mechanistically, circSHPRH acted as a tumor suppressor at least partly by inhibiting PI3K/AKT/mTOR signaling, and higher expression was associated with better overall survival.
0.8169
CircSHPRH inhibits malignancy progression of head and neck squamous cell carcinoma by regulating PI3K/AKT/mTOR signaling pathway.
combined biological and clinical study